A Clinical Trial on the Antipsychotic Properties of Cannabidiol

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
The purpose of this study is to determine whether cannabidiol, a herbal cannabinoid, is effective in the treatment of acute schizophrenic or schizophreniform psychosis in a placebo-controlled, randomized double-blind study.
Epistemonikos ID: d8123565f5b66cc39f7ee4c009a171082adda915
First added on: Jul 16, 2015